Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 4 1Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 13Carcinoma, Renal Cell 6Tuberous Sclerosis 5Neoplasm Metastasis 5Hodgkin Disease 5Glioblastoma 5Colorectal Neoplasms 5Central Nervous System Neoplasms 5Waldenstrom Macroglobulinemia 4Stomach Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Lymphoma, Mantle-Cell 4Head and Neck Neoplasms 4Gliosarcoma 4Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Sezary Syndrome 3Recurrence 3Prostatic Neoplasms 3Neoplasms 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Kidney Neoplasms 3

Interventions

Everolimus 2carbon-11 acetate 1Sirolimus 1Simvastatin 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Lymphangioleiomyomatosis × Everolimus × Clear all
NCT02061397 2020-08-25

SOS

University of Pennsylvania

Phase 1/2 Completed
10 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT00457964 2013-09-25

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Children's Hospital Medical Center, Cincinnati

Phase 1/2 Completed
36 enrolled

Hereditary Sensory and Autonomic Neuropathies, Tuberous Sclerosis, Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡